1-[(3R)-2-tert-butyl-3,5-dimethyl-2-azabicyclo[3.1.0]hexan-4-yl]-N,N-dimethylmethanamine;[(3R)-2-tert-butyl-3,5-dimethyl-2-azabicyclo[3.1.0]hexan-4-yl]methanamine;4-[[(3R)-2-tert-butyl-3,5-dimethyl-2-azabicyclo[3.1.0]hexan-4-yl]methyl]morpholine;(3R)-2-tert-butyl-3,5-dimethyl-4-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;1-[(5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-3-yl]-N,N-dimethylmethanamine;4-[[(3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]morpholine;1-[[(3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]piperazine;1-[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-4-yl]-N,N-dimethylmethanamine;1-[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-5-yl]-N,N-dimethylmethanamine;[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-4-yl]methanamine;4-[[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-4-yl]methyl]morpholine;4-[[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-5-yl]methyl]morpholine;(3R)-2-tert-butyl-3-methyl-4-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;(3R)-2-tert-butyl-3-methyl-5-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;ethane

C223H465F3N32O4 — CID 159331427

IUPAC1-[(3R)-2-tert-butyl-3,5-dimethyl-2-azabicyclo[3.1.0]hexan-4-yl]-N,N-dimethylmethanamine;[(3R)-2-tert-butyl-3,5-dimethyl-2-azabicyclo[3.1.0]hexan-4-yl]methanamine;4-[[(3R)-2-tert-butyl-3,5-dimethyl-2-azabicyclo[3.1.0]hexan-4-yl]methyl]morpholine;(3R)-2-tert-butyl-3,5-dimethyl-4-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;1-[(5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-3-yl]-N,N-dimethylmethanamine;4-[[(3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]morpholine;1-[[(3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]piperazine;1-[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-4-yl]-N,N-dimethylmethanamine;1-[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-5-yl]-N,N-dimethylmethanamine;[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-4-yl]methanamine;4-[[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-4-yl]methyl]morpholine;4-[[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-5-yl]methyl]morpholine;(3R)-2-tert-butyl-3-methyl-4-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;(3R)-2-tert-butyl-3-methyl-5-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;ethane
SMILESCC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.C[C@@H]1C(CN(C)C)C2(C)CC2N1C(C)(C)C.C[C@@H]1C(CN(C)C)C2CC2N1C(C)(C)C.C[C@@H]1C(CN)C2(C)CC2N1C(C)(C)C.C[C@@H]1C(CN)C2CC2N1C(C)(C)C.C[C@@H]1C(CN2CCNCC2)C2(C)CC2N1C(C)(C)C.C[C@@H]1C(CN2CCNCC2)C2CC2N1C(C)(C)C.C[C@@H]1C(CN2CCOCC2)C2(C)CC2N1C(C)(C)C.C[C@@H]1C(CN2CCOCC2)C2CC2N1C(C)(C)C.C[C@@H]1CC(F)(CN(C)C)CN1C(C)(C)C.C[C@@H]1CC2(CN(C)C)CC2N1C(C)(C)C.C[C@@H]1CC2(CN3CCNCC3)CC2N1C(C)(C)C.C[C@@H]1CC2(CN3CCOCC3)CC2N1C(C)(C)C.C[C@@H]1C[C@@H](F)C(CN2CCNCC2)N1C(C)(C)C.C[C@@H]1C[C@@H](F)C(CN2CCOCC2)N1C(C)(C)C
InChIInChI=1S/C16H31N3.C16H30N2O.2C15H29N3.2C15H28N2O.C14H28FN3.C14H27FN2O.C14H28N2.2C13H26N2.C12H25FN2.C12H24N2.C11H22N2.14C2H6/c1-12-13(11-18-8-6-17-7-9-18)16(5)10-14(16)19(12)15(2,3)4;1-12-13(11-17-6-8-19-9-7-17)16(5)10-14(16)18(12)15(2,3)4;1-12-9-15(11-17-7-5-16-6-8-17)10-13(15)18(12)14(2,3)4;1-11-13(10-17-7-5-16-6-8-17)12-9-14(12)18(11)15(2,3)4;1-12-9-15(11-16-5-7-18-8-6-16)10-13(15)17(12)14(2,3)4;1-11-13(10-16-5-7-18-8-6-16)12-9-14(12)17(11)15(2,3)4;1-11-9-12(15)13(18(11)14(2,3)4)10-17-7-5-16-6-8-17;1-11-9-12(15)13(17(11)14(2,3)4)10-16-5-7-18-8-6-16;1-10-11(9-15(6)7)14(5)8-12(14)16(10)13(2,3)4;1-10-7-13(9-14(5)6)8-11(13)15(10)12(2,3)4;1-9-11(8-14(5)6)10-7-12(10)15(9)13(2,3)4;1-10-7-12(13,8-14(5)6)9-15(10)11(2,3)4;1-8-9(7-13)12(5)6-10(12)14(8)11(2,3)4;1-7-9(6-12)8-5-10(8)13(7)11(2,3)4;14*1-2/h12-14,17H,6-11H2,1-5H3;12-14H,6-11H2,1-5H3;12-13,16H,5-11H2,1-4H3;11-14,16H,5-10H2,1-4H3;12-13H,5-11H2,1-4H3;11-14H,5-10H2,1-4H3;11-13,16H,5-10H2,1-4H3;11-13H,5-10H2,1-4H3;10-12H,8-9H2,1-7H3;10-11H,7-9H2,1-6H3;9-12H,7-8H2,1-6H3;10H,7-9H2,1-6H3;8-10H,6-7,13H2,1-5H3;7-10H,5-6,12H2,1-4H3;14*1-2H3/t2*12-,13?,14?,16?;12-,13?,15?;11-,12?,13?,14?;12-,13?,15?;11-,12?,13?,14?;2*11-,12-,13?;10-,11?,12?,14?;10-,11?,13?;9-,10?,11?,12?;10-,12?;8-,9?,10?,12?;7-,8?,9?,10?;;;;;;;;;;;;;;/m11111111111111............../s1
InChIKeyLEZYZYLWYSMESO-YCGWKSRPSA-N
MW3716.39 g/mol
LogP40.66
Rot. Bonds26

About 1-[(3R)-2-tert-butyl-3,5-dimethyl-2-azabicyclo[3.1.0]hexan-4-yl]-N,N-dimethylmethanamine;[(3R)-2-tert-butyl-3,5-dimethyl-2-azabicyclo[3.1.0]hexan-4-yl]methanamine;4-[[(3R)-2-tert-butyl-3,5-dimethyl-2-azabicyclo[3.1.0]hexan-4-yl]methyl]morpholine;(3R)-2-tert-butyl-3,5-dimethyl-4-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;1-[(5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-3-yl]-N,N-dimethylmethanamine;4-[[(3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]morpholine;1-[[(3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]piperazine;1-[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-4-yl]-N,N-dimethylmethanamine;1-[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-5-yl]-N,N-dimethylmethanamine;[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-4-yl]methanamine;4-[[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-4-yl]methyl]morpholine;4-[[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-5-yl]methyl]morpholine;(3R)-2-tert-butyl-3-methyl-4-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;(3R)-2-tert-butyl-3-methyl-5-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;ethane

1-[(3R)-2-tert-butyl-3,5-dimethyl-2-azabicyclo[3.1.0]hexan-4-yl]-N,N-dimethylmethanamine;[(3R)-2-tert-butyl-3,5-dimethyl-2-azabicyclo[3.1.0]hexan-4-yl]methanamine;4-[[(3R)-2-tert-butyl-3,5-dimethyl-2-azabicyclo[3.1.0]hexan-4-yl]methyl]morpholine;(3R)-2-tert-butyl-3,5-dimethyl-4-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;1-[(5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-3-yl]-N,N-dimethylmethanamine;4-[[(3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]morpholine;1-[[(3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]piperazine;1-[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-4-yl]-N,N-dimethylmethanamine;1-[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-5-yl]-N,N-dimethylmethanamine;[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-4-yl]methanamine;4-[[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-4-yl]methyl]morpholine;4-[[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-5-yl]methyl]morpholine;(3R)-2-tert-butyl-3-methyl-4-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;(3R)-2-tert-butyl-3-methyl-5-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;ethane (PubChem CID 159331427) has the molecular formula C223H465F3N32O4 and a molecular weight of 3716.39 g/mol. Its IUPAC name is 1-[(3R)-2-tert-butyl-3,5-dimethyl-2-azabicyclo[3.1.0]hexan-4-yl]-N,N-dimethylmethanamine;[(3R)-2-tert-butyl-3,5-dimethyl-2-azabicyclo[3.1.0]hexan-4-yl]methanamine;4-[[(3R)-2-tert-butyl-3,5-dimethyl-2-azabicyclo[3.1.0]hexan-4-yl]methyl]morpholine;(3R)-2-tert-butyl-3,5-dimethyl-4-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;1-[(5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-3-yl]-N,N-dimethylmethanamine;4-[[(3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]morpholine;1-[[(3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]piperazine;1-[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-4-yl]-N,N-dimethylmethanamine;1-[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-5-yl]-N,N-dimethylmethanamine;[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-4-yl]methanamine;4-[[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-4-yl]methyl]morpholine;4-[[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-5-yl]methyl]morpholine;(3R)-2-tert-butyl-3-methyl-4-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;(3R)-2-tert-butyl-3-methyl-5-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;ethane.

Molecular Properties

Compound Name1-[(3R)-2-tert-butyl-3,5-dimethyl-2-azabicyclo[3.1.0]hexan-4-yl]-N,N-dimethylmethanamine;[(3R)-2-tert-butyl-3,5-dimethyl-2-azabicyclo[3.1.0]hexan-4-yl]methanamine;4-[[(3R)-2-tert-butyl-3,5-dimethyl-2-azabicyclo[3.1.0]hexan-4-yl]methyl]morpholine;(3R)-2-tert-butyl-3,5-dimethyl-4-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;1-[(5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-3-yl]-N,N-dimethylmethanamine;4-[[(3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]morpholine;1-[[(3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]piperazine;1-[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-4-yl]-N,N-dimethylmethanamine;1-[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-5-yl]-N,N-dimethylmethanamine;[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-4-yl]methanamine;4-[[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-4-yl]methyl]morpholine;4-[[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-5-yl]methyl]morpholine;(3R)-2-tert-butyl-3-methyl-4-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;(3R)-2-tert-butyl-3-methyl-5-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;ethane
PubChem CID159331427
Molecular FormulaC223H465F3N32O4
Molecular Weight3716.39 g/mol
Exact Mass3713.71
IUPAC Name1-[(3R)-2-tert-butyl-3,5-dimethyl-2-azabicyclo[3.1.0]hexan-4-yl]-N,N-dimethylmethanamine;[(3R)-2-tert-butyl-3,5-dimethyl-2-azabicyclo[3.1.0]hexan-4-yl]methanamine;4-[[(3R)-2-tert-butyl-3,5-dimethyl-2-azabicyclo[3.1.0]hexan-4-yl]methyl]morpholine;(3R)-2-tert-butyl-3,5-dimethyl-4-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;1-[(5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-3-yl]-N,N-dimethylmethanamine;4-[[(3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]morpholine;1-[[(3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]piperazine;1-[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-4-yl]-N,N-dimethylmethanamine;1-[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-5-yl]-N,N-dimethylmethanamine;[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-4-yl]methanamine;4-[[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-4-yl]methyl]morpholine;4-[[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-5-yl]methyl]morpholine;(3R)-2-tert-butyl-3-methyl-4-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;(3R)-2-tert-butyl-3-methyl-5-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;ethane
SMILESCC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.C[C@@H]1C(CN(C)C)C2(C)CC2N1C(C)(C)C.C[C@@H]1C(CN(C)C)C2CC2N1C(C)(C)C.C[C@@H]1C(CN)C2(C)CC2N1C(C)(C)C.C[C@@H]1C(CN)C2CC2N1C(C)(C)C.C[C@@H]1C(CN2CCNCC2)C2(C)CC2N1C(C)(C)C.C[C@@H]1C(CN2CCNCC2)C2CC2N1C(C)(C)C.C[C@@H]1C(CN2CCOCC2)C2(C)CC2N1C(C)(C)C.C[C@@H]1C(CN2CCOCC2)C2CC2N1C(C)(C)C.C[C@@H]1CC(F)(CN(C)C)CN1C(C)(C)C.C[C@@H]1CC2(CN(C)C)CC2N1C(C)(C)C.C[C@@H]1CC2(CN3CCNCC3)CC2N1C(C)(C)C.C[C@@H]1CC2(CN3CCOCC3)CC2N1C(C)(C)C.C[C@@H]1C[C@@H](F)C(CN2CCNCC2)N1C(C)(C)C.C[C@@H]1C[C@@H](F)C(CN2CCOCC2)N1C(C)(C)C
InChIInChI=1S/C16H31N3.C16H30N2O.2C15H29N3.2C15H28N2O.C14H28FN3.C14H27FN2O.C14H28N2.2C13H26N2.C12H25FN2.C12H24N2.C11H22N2.14C2H6/c1-12-13(11-18-8-6-17-7-9-18)16(5)10-14(16)19(12)15(2,3)4;1-12-13(11-17-6-8-19-9-7-17)16(5)10-14(16)18(12)15(2,3)4;1-12-9-15(11-17-7-5-16-6-8-17)10-13(15)18(12)14(2,3)4;1-11-13(10-17-7-5-16-6-8-17)12-9-14(12)18(11)15(2,3)4;1-12-9-15(11-16-5-7-18-8-6-16)10-13(15)17(12)14(2,3)4;1-11-13(10-16-5-7-18-8-6-16)12-9-14(12)17(11)15(2,3)4;1-11-9-12(15)13(18(11)14(2,3)4)10-17-7-5-16-6-8-17;1-11-9-12(15)13(17(11)14(2,3)4)10-16-5-7-18-8-6-16;1-10-11(9-15(6)7)14(5)8-12(14)16(10)13(2,3)4;1-10-7-13(9-14(5)6)8-11(13)15(10)12(2,3)4;1-9-11(8-14(5)6)10-7-12(10)15(9)13(2,3)4;1-10-7-12(13,8-14(5)6)9-15(10)11(2,3)4;1-8-9(7-13)12(5)6-10(12)14(8)11(2,3)4;1-7-9(6-12)8-5-10(8)13(7)11(2,3)4;14*1-2/h12-14,17H,6-11H2,1-5H3;12-14H,6-11H2,1-5H3;12-13,16H,5-11H2,1-4H3;11-14,16H,5-10H2,1-4H3;12-13H,5-11H2,1-4H3;11-14H,5-10H2,1-4H3;11-13,16H,5-10H2,1-4H3;11-13H,5-10H2,1-4H3;10-12H,8-9H2,1-7H3;10-11H,7-9H2,1-6H3;9-12H,7-8H2,1-6H3;10H,7-9H2,1-6H3;8-10H,6-7,13H2,1-5H3;7-10H,5-6,12H2,1-4H3;14*1-2H3/t2*12-,13?,14?,16?;12-,13?,15?;11-,12?,13?,14?;12-,13?,15?;11-,12?,13?,14?;2*11-,12-,13?;10-,11?,12?,14?;10-,11?,13?;9-,10?,11?,12?;10-,12?;8-,9?,10?,12?;7-,8?,9?,10?;;;;;;;;;;;;;;/m11111111111111............../s1
InChIKeyLEZYZYLWYSMESO-YCGWKSRPSA-N
XLogP40.66
TPSA221.32 Ų
H-Bond Donors6
H-Bond Acceptors36
Rotatable Bonds26
Heavy Atoms262
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5003716.39
LogP ≤ 540.66
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1036

Analyze 1-[(3R)-2-tert-butyl-3,5-dimethyl-2-azabicyclo[3.1.0]hexan-4-yl]-N,N-dimethylmethanamine;[(3R)-2-tert-butyl-3,5-dimethyl-2-azabicyclo[3.1.0]hexan-4-yl]methanamine;4-[[(3R)-2-tert-butyl-3,5-dimethyl-2-azabicyclo[3.1.0]hexan-4-yl]methyl]morpholine;(3R)-2-tert-butyl-3,5-dimethyl-4-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;1-[(5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-3-yl]-N,N-dimethylmethanamine;4-[[(3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]morpholine;1-[[(3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]piperazine;1-[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-4-yl]-N,N-dimethylmethanamine;1-[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-5-yl]-N,N-dimethylmethanamine;[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-4-yl]methanamine;4-[[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-4-yl]methyl]morpholine;4-[[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-5-yl]methyl]morpholine;(3R)-2-tert-butyl-3-methyl-4-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;(3R)-2-tert-butyl-3-methyl-5-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;ethane with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 1-[(3R)-2-tert-butyl-3,5-dimethyl-2-azabicyclo[3.1.0]hexan-4-yl]-N,N-dimethylmethanamine;[(3R)-2-tert-butyl-3,5-dimethyl-2-azabicyclo[3.1.0]hexan-4-yl]methanamine;4-[[(3R)-2-tert-butyl-3,5-dimethyl-2-azabicyclo[3.1.0]hexan-4-yl]methyl]morpholine;(3R)-2-tert-butyl-3,5-dimethyl-4-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;1-[(5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-3-yl]-N,N-dimethylmethanamine;4-[[(3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]morpholine;1-[[(3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]piperazine;1-[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-4-yl]-N,N-dimethylmethanamine;1-[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-5-yl]-N,N-dimethylmethanamine;[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-4-yl]methanamine;4-[[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-4-yl]methyl]morpholine;4-[[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-5-yl]methyl]morpholine;(3R)-2-tert-butyl-3-methyl-4-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;(3R)-2-tert-butyl-3-methyl-5-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;ethane?
The IUPAC name of 1-[(3R)-2-tert-butyl-3,5-dimethyl-2-azabicyclo[3.1.0]hexan-4-yl]-N,N-dimethylmethanamine;[(3R)-2-tert-butyl-3,5-dimethyl-2-azabicyclo[3.1.0]hexan-4-yl]methanamine;4-[[(3R)-2-tert-butyl-3,5-dimethyl-2-azabicyclo[3.1.0]hexan-4-yl]methyl]morpholine;(3R)-2-tert-butyl-3,5-dimethyl-4-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;1-[(5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-3-yl]-N,N-dimethylmethanamine;4-[[(3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]morpholine;1-[[(3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]piperazine;1-[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-4-yl]-N,N-dimethylmethanamine;1-[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-5-yl]-N,N-dimethylmethanamine;[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-4-yl]methanamine;4-[[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-4-yl]methyl]morpholine;4-[[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-5-yl]methyl]morpholine;(3R)-2-tert-butyl-3-methyl-4-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;(3R)-2-tert-butyl-3-methyl-5-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;ethane (CID 159331427) is 1-[(3R)-2-tert-butyl-3,5-dimethyl-2-azabicyclo[3.1.0]hexan-4-yl]-N,N-dimethylmethanamine;[(3R)-2-tert-butyl-3,5-dimethyl-2-azabicyclo[3.1.0]hexan-4-yl]methanamine;4-[[(3R)-2-tert-butyl-3,5-dimethyl-2-azabicyclo[3.1.0]hexan-4-yl]methyl]morpholine;(3R)-2-tert-butyl-3,5-dimethyl-4-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;1-[(5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-3-yl]-N,N-dimethylmethanamine;4-[[(3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]morpholine;1-[[(3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]piperazine;1-[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-4-yl]-N,N-dimethylmethanamine;1-[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-5-yl]-N,N-dimethylmethanamine;[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-4-yl]methanamine;4-[[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-4-yl]methyl]morpholine;4-[[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-5-yl]methyl]morpholine;(3R)-2-tert-butyl-3-methyl-4-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;(3R)-2-tert-butyl-3-methyl-5-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;ethane.
What is the SMILES notation for 1-[(3R)-2-tert-butyl-3,5-dimethyl-2-azabicyclo[3.1.0]hexan-4-yl]-N,N-dimethylmethanamine;[(3R)-2-tert-butyl-3,5-dimethyl-2-azabicyclo[3.1.0]hexan-4-yl]methanamine;4-[[(3R)-2-tert-butyl-3,5-dimethyl-2-azabicyclo[3.1.0]hexan-4-yl]methyl]morpholine;(3R)-2-tert-butyl-3,5-dimethyl-4-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;1-[(5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-3-yl]-N,N-dimethylmethanamine;4-[[(3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]morpholine;1-[[(3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]piperazine;1-[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-4-yl]-N,N-dimethylmethanamine;1-[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-5-yl]-N,N-dimethylmethanamine;[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-4-yl]methanamine;4-[[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-4-yl]methyl]morpholine;4-[[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-5-yl]methyl]morpholine;(3R)-2-tert-butyl-3-methyl-4-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;(3R)-2-tert-butyl-3-methyl-5-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;ethane?
The canonical SMILES for 1-[(3R)-2-tert-butyl-3,5-dimethyl-2-azabicyclo[3.1.0]hexan-4-yl]-N,N-dimethylmethanamine;[(3R)-2-tert-butyl-3,5-dimethyl-2-azabicyclo[3.1.0]hexan-4-yl]methanamine;4-[[(3R)-2-tert-butyl-3,5-dimethyl-2-azabicyclo[3.1.0]hexan-4-yl]methyl]morpholine;(3R)-2-tert-butyl-3,5-dimethyl-4-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;1-[(5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-3-yl]-N,N-dimethylmethanamine;4-[[(3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]morpholine;1-[[(3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]piperazine;1-[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-4-yl]-N,N-dimethylmethanamine;1-[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-5-yl]-N,N-dimethylmethanamine;[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-4-yl]methanamine;4-[[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-4-yl]methyl]morpholine;4-[[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-5-yl]methyl]morpholine;(3R)-2-tert-butyl-3-methyl-4-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;(3R)-2-tert-butyl-3-methyl-5-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;ethane is CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.C[C@@H]1C(CN(C)C)C2(C)CC2N1C(C)(C)C.C[C@@H]1C(CN(C)C)C2CC2N1C(C)(C)C.C[C@@H]1C(CN)C2(C)CC2N1C(C)(C)C.C[C@@H]1C(CN)C2CC2N1C(C)(C)C.C[C@@H]1C(CN2CCNCC2)C2(C)CC2N1C(C)(C)C.C[C@@H]1C(CN2CCNCC2)C2CC2N1C(C)(C)C.C[C@@H]1C(CN2CCOCC2)C2(C)CC2N1C(C)(C)C.C[C@@H]1C(CN2CCOCC2)C2CC2N1C(C)(C)C.C[C@@H]1CC(F)(CN(C)C)CN1C(C)(C)C.C[C@@H]1CC2(CN(C)C)CC2N1C(C)(C)C.C[C@@H]1CC2(CN3CCNCC3)CC2N1C(C)(C)C.C[C@@H]1CC2(CN3CCOCC3)CC2N1C(C)(C)C.C[C@@H]1C[C@@H](F)C(CN2CCNCC2)N1C(C)(C)C.C[C@@H]1C[C@@H](F)C(CN2CCOCC2)N1C(C)(C)C.
What is the InChIKey of 1-[(3R)-2-tert-butyl-3,5-dimethyl-2-azabicyclo[3.1.0]hexan-4-yl]-N,N-dimethylmethanamine;[(3R)-2-tert-butyl-3,5-dimethyl-2-azabicyclo[3.1.0]hexan-4-yl]methanamine;4-[[(3R)-2-tert-butyl-3,5-dimethyl-2-azabicyclo[3.1.0]hexan-4-yl]methyl]morpholine;(3R)-2-tert-butyl-3,5-dimethyl-4-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;1-[(5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-3-yl]-N,N-dimethylmethanamine;4-[[(3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]morpholine;1-[[(3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]piperazine;1-[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-4-yl]-N,N-dimethylmethanamine;1-[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-5-yl]-N,N-dimethylmethanamine;[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-4-yl]methanamine;4-[[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-4-yl]methyl]morpholine;4-[[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-5-yl]methyl]morpholine;(3R)-2-tert-butyl-3-methyl-4-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;(3R)-2-tert-butyl-3-methyl-5-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;ethane?
The InChIKey is LEZYZYLWYSMESO-YCGWKSRPSA-N. The full InChI is InChI=1S/C16H31N3.C16H30N2O.2C15H29N3.2C15H28N2O.C14H28FN3.C14H27FN2O.C14H28N2.2C13H26N2.C12H25FN2.C12H24N2.C11H22N2.14C2H6/c1-12-13(11-18-8-6-17-7-9-18)16(5)10-14(16)19(12)15(2,3)4;1-12-13(11-17-6-8-19-9-7-17)16(5)10-14(16)18(12)15(2,3)4;1-12-9-15(11-17-7-5-16-6-8-17)10-13(15)18(12)14(2,3)4;1-11-13(10-17-7-5-16-6-8-17)12-9-14(12)18(11)15(2,3)4;1-12-9-15(11-16-5-7-18-8-6-16)10-13(15)17(12)14(2,3)4;1-11-13(10-16-5-7-18-8-6-16)12-9-14(12)17(11)15(2,3)4;1-11-9-12(15)13(18(11)14(2,3)4)10-17-7-5-16-6-8-17;1-11-9-12(15)13(17(11)14(2,3)4)10-16-5-7-18-8-6-16;1-10-11(9-15(6)7)14(5)8-12(14)16(10)13(2,3)4;1-10-7-13(9-14(5)6)8-11(13)15(10)12(2,3)4;1-9-11(8-14(5)6)10-7-12(10)15(9)13(2,3)4;1-10-7-12(13,8-14(5)6)9-15(10)11(2,3)4;1-8-9(7-13)12(5)6-10(12)14(8)11(2,3)4;1-7-9(6-12)8-5-10(8)13(7)11(2,3)4;14*1-2/h12-14,17H,6-11H2,1-5H3;12-14H,6-11H2,1-5H3;12-13,16H,5-11H2,1-4H3;11-14,16H,5-10H2,1-4H3;12-13H,5-11H2,1-4H3;11-14H,5-10H2,1-4H3;11-13,16H,5-10H2,1-4H3;11-13H,5-10H2,1-4H3;10-12H,8-9H2,1-7H3;10-11H,7-9H2,1-6H3;9-12H,7-8H2,1-6H3;10H,7-9H2,1-6H3;8-10H,6-7,13H2,1-5H3;7-10H,5-6,12H2,1-4H3;14*1-2H3/t2*12-,13?,14?,16?;12-,13?,15?;11-,12?,13?,14?;12-,13?,15?;11-,12?,13?,14?;2*11-,12-,13?;10-,11?,12?,14?;10-,11?,13?;9-,10?,11?,12?;10-,12?;8-,9?,10?,12?;7-,8?,9?,10?;;;;;;;;;;;;;;/m11111111111111............../s1.
What are the key properties of 1-[(3R)-2-tert-butyl-3,5-dimethyl-2-azabicyclo[3.1.0]hexan-4-yl]-N,N-dimethylmethanamine;[(3R)-2-tert-butyl-3,5-dimethyl-2-azabicyclo[3.1.0]hexan-4-yl]methanamine;4-[[(3R)-2-tert-butyl-3,5-dimethyl-2-azabicyclo[3.1.0]hexan-4-yl]methyl]morpholine;(3R)-2-tert-butyl-3,5-dimethyl-4-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;1-[(5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-3-yl]-N,N-dimethylmethanamine;4-[[(3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]morpholine;1-[[(3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]piperazine;1-[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-4-yl]-N,N-dimethylmethanamine;1-[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-5-yl]-N,N-dimethylmethanamine;[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-4-yl]methanamine;4-[[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-4-yl]methyl]morpholine;4-[[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-5-yl]methyl]morpholine;(3R)-2-tert-butyl-3-methyl-4-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;(3R)-2-tert-butyl-3-methyl-5-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;ethane?
1-[(3R)-2-tert-butyl-3,5-dimethyl-2-azabicyclo[3.1.0]hexan-4-yl]-N,N-dimethylmethanamine;[(3R)-2-tert-butyl-3,5-dimethyl-2-azabicyclo[3.1.0]hexan-4-yl]methanamine;4-[[(3R)-2-tert-butyl-3,5-dimethyl-2-azabicyclo[3.1.0]hexan-4-yl]methyl]morpholine;(3R)-2-tert-butyl-3,5-dimethyl-4-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;1-[(5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-3-yl]-N,N-dimethylmethanamine;4-[[(3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]morpholine;1-[[(3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]piperazine;1-[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-4-yl]-N,N-dimethylmethanamine;1-[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-5-yl]-N,N-dimethylmethanamine;[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-4-yl]methanamine;4-[[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-4-yl]methyl]morpholine;4-[[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-5-yl]methyl]morpholine;(3R)-2-tert-butyl-3-methyl-4-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;(3R)-2-tert-butyl-3-methyl-5-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;ethane has a molecular weight of 3716.39 g/mol, XLogP of 40.66, 26 rotatable bonds, 6 hydrogen bond donors, and 36 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[(3R)-2-tert-butyl-3,5-dimethyl-2-azabicyclo[3.1.0]hexan-4-yl]-N,N-dimethylmethanamine;[(3R)-2-tert-butyl-3,5-dimethyl-2-azabicyclo[3.1.0]hexan-4-yl]methanamine;4-[[(3R)-2-tert-butyl-3,5-dimethyl-2-azabicyclo[3.1.0]hexan-4-yl]methyl]morpholine;(3R)-2-tert-butyl-3,5-dimethyl-4-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;1-[(5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-3-yl]-N,N-dimethylmethanamine;4-[[(3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]morpholine;1-[[(3R,5R)-1-tert-butyl-3-fluoro-5-methylpyrrolidin-2-yl]methyl]piperazine;1-[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-4-yl]-N,N-dimethylmethanamine;1-[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-5-yl]-N,N-dimethylmethanamine;[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-4-yl]methanamine;4-[[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-4-yl]methyl]morpholine;4-[[(3R)-2-tert-butyl-3-methyl-2-azabicyclo[3.1.0]hexan-5-yl]methyl]morpholine;(3R)-2-tert-butyl-3-methyl-4-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;(3R)-2-tert-butyl-3-methyl-5-(piperazin-1-ylmethyl)-2-azabicyclo[3.1.0]hexane;ethane is sourced from PubChem (CID 159331427), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).